On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayApr 13, 2017 1:59 pm

NetworkNewsBreaks – Function(x), Inc. (NASDAQ: FNCX) Receives $3.20 PT from SeeThruEquity

SeeThruEquity has initiated coverage and issued a price target of $3.20 on shares of Function(x), Inc. (NASDAQ: FNCX). The analyst noted that the company’s media properties, Wetpaint and Rant, had approximately 210 million page views in March and have over 10 million social media followers. The analyst also cited the company’s steps to restructure its balance sheet, demonstrated by the $4.8 million new equity capital raised in February. Function(x) is also evaluating the sale of non-core assets and is in the process of renegotiating its debt. For more information, visit www.functionxinc.com About Function(x), Inc. Function(x) operates Wetpaint.com and Rant. Wetpaint…

Continue Reading

ThursdayApr 13, 2017 1:57 pm

NetworkNewsBreaks – SeeThruEquity Updates Coverage on Net Element, Inc. (NASDAQ: NETE), Issues $2.45 PT

SeeThruEquity has issued a company update and reaffirmed its price target of $2.45 on shares of Net Element, Inc. (NASDAQ: NETE). Among other highlights, the analyst notes NETE’s full-year 2016 revenue growth of 35% to $54.3 million, driven by strength in its largest segment, North American Transaction, and an increase in the volume of transactions processed on NETE's platform, which rose by 40% versus 2015, to reach $2.45 billion. NETE’s NA Transactions segment consists of Unified Payments, a provider of comprehensive turnkey payment processing solutions, as well as Aptito, a cloud-based restaurant management solution. For more information, visit www.netelement.com About…

Continue Reading

ThursdayApr 13, 2017 11:57 am

NetworkNewsBreaks – Intellipharmaceutics International, Inc. (NASDAQ: IPCI) Receives ‘Hold’ Rating, Reduced PT at Aegis Capital

Aegis Capital has issued a ‘Hold’ rating and a lowered price target of $2 on shares of Intellipharmaceutics International (NASDAQ: IPCI). The news follows recent patent litigation from Purdue Pharma against Intellipharmaceutics regarding the New Drug Application (“NDA”) filing for its Rexista™ product candidate. The FDA is stayed for 30 months from granting final approval to the company’s Rexista™ as a result of these legal proceedings, unless a final declaration of the courts is entered that the patents are either invalid or are not infringed, or the matter is otherwise settled among the parties. The analyst noted the patent suit,…

Continue Reading

ThursdayApr 13, 2017 11:53 am

NetworkNewsBreaks – Aegis Capital Reiterates ‘Buy’ Rating, $25 PT on Concert Pharmaceuticals, Inc. (NASDAQ: CNCE)

Aegis Capital Corp. has reiterated a ‘Buy’ rating and $25 price target on the stock of Concert Pharmaceuticals, Inc. (NASDAQ: CNCE). The report follows the unexpected delay of the company’s CTP-543 phase 2a trial for alopecia areata. The delay of one quarter was caused by the tablet being unable to meet release criteria regarding appearance. The analyst noted this delay as insignificant and reiterated the ‘Buy’ rating. For more information visit www.concertpharma.com About Concert Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet…

Continue Reading

WednesdayApr 05, 2017 12:33 pm

NetworkNewsBreaks – Matinas BioPharma Holdings, Inc. (NYSE: MTNB) Receives ‘Buy’ Rating, $8 PT at Aegis Capital

Aegis Capital has issued a ‘Buy’ rating and price target of $8 on shares of Matinas BioPharma’s (NYSE: MTNB) stock. The news follows the company’s report of financial results for the year ended December 31, 2016, for which the company reported cash and cash equivalents of approximately $4.1 million. The analyst noted this cash position and said he expects the company to end the first quarter of 2017 with approximately $14 million and enough cash to fund operations through the second quarter of 2018. The company also recently provided a clinical update, such as plans to initiate a study of…

Continue Reading

MondayApr 03, 2017 12:25 pm

NetworkNewsBreaks – Biocept, Inc. (NASDAQ: BIOC) Engages ROTH Capital Partners as Lead Placement Agent in $9.3M Registered Direct; Enters Agreement with Oregon Health & Sciences University

Biocept (NASDAQ: BIOC) recently completed a sale of 4,320,000 shares of common stock at a price of $2.15 per share, with ROTH Capital Partners as lead placement agent in the offering. The gross proceeds of the offering are expected to be approximately $9.3 million, which the company intends to use the proceeds for working capital and general corporate purposes. Additionally, the company said today that is has entered into a Preferred Provider Collaboration and Services Agreement with Oregon Health & Sciences University on behalf of the OHSU Knight Cancer Institute (collectively OHSU). Per the multiphase agreement, OHSU is granted the…

Continue Reading

FridayMar 31, 2017 12:52 pm

NetworkNewsBreaks – SeeThruEquity Issues Update and PT of $10.50 on IEG Holdings Corp. (IEGH)

SeeThruEquity recently issued an update and a price target of $10.50 on shares of IEG Holdings (OTCQX: IEGH). The company reported record revenues of $2.1 million for the full year 2016, a year-over-year increase of 16.3% driven by strong loan volume growth. The SeeThruEquity analyst cited the key factors driving loan growth, including low acquisition costs and continued expansion of state licenses. IEG has outlined a target of expanding to 25 states and covering 75% of the population in 2017. For more information, visit www.investmentevolution.com About IEG Holdings Corporation IEG Holdings Corporation provides online unsecured consumer loans under the brand…

Continue Reading

FridayMar 31, 2017 12:50 pm

NetworkNewsBreaks – SeeThruEquity Issues Update on Nephros, Inc. (NEPH), PT Steady at $1.65

SeeThruEquity recently updated its coverage and price target of $1.65 on Nephros (OTCQB: NEPH) common stock. In its financial results for the three months and full-year ended December 31, 2016, Nephros reported full-year revenue growth of 19% to $2.3 million, among other financial highlights of the year. Product updates include receiving 510(k) clearance for new 10" filters for HydraGuard™ for infection control and EndoPur™ for hemodialysis. The company plans to launch the product in the second quarter of 2017. Nephros said it expects to grow product revenues by 100% in 2017 and set a goal of reaching cash flow breakeven…

Continue Reading

FridayMar 31, 2017 11:18 am

NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Prices $4.5M Public Offering; Shares Drop

Shares of DarioHealth (NASDAQ: DRIO) dropped 22% in morning trade after the company released the pricing of an underwritten public offering of 1,450,000 shares of its common stock at a public offering price of $3.10 per share. Gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $4.5 million. Dario intends to use the net proceeds toward commercialization efforts of its products and for general working capital purposes. Subject to customary closing conditions, the offering is expected to close on April 5, 2017. To view the full press release,…

Continue Reading

ThursdayMar 30, 2017 1:11 pm

NetworkNewsBreaks – Moxian (NASDAQ: MOXC) Anticipated to Reach Revenues of Over $62M in 2020

SeeThruEquity recently issued a research report on Moxian (NASDAQ: MOXC) which estimates sales of more than $62 million and a gross profit of more than $39 million in FY 2020 (http://nnw.fm/T6Aj4). “In the O2O market, online consumers are attracted to brick and mortar stores through various incentives. Moxian is expected to launch its paid Moxian+ platform this year. To the 75 million small- and medium-sized businesses in China, Moxian will offer its premium services for a fee. Services on its Moxian+ Business App would include access to analytics, hosting of online shops, targeted marketing, and the ability to host social…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217